Bradley Glover
Chief Operating Officer at IMUGENE LIMITED
Net worth: 183 672 $ as of 31/03/2024
Profile
Bradley Glover is currently the Chief Operating Officer at Imugene Ltd.
He previously worked as the Vice President of Corporate Development at Kite Pharma, Inc. and as the Chief Technology Officer and Executive Vice President at Celularity, Inc. (United States).
He also served as the Chief Operating Officer and Executive Vice President at Celularity, Inc. from 2021 to 2023.
Dr. Glover received his undergraduate degree from the University of California San Diego, his doctorate from the University of Colorado, and his MBA from the Rady School of Management at UC San Diego.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CELULARITY INC. CLASS A
0.16% | 13/04/2023 | 35,119 ( 0.16% ) | 183 672 $ | 31/03/2024 |
Bradley Glover active positions
| Companies | Position | Start |
|---|---|---|
| IMUGENE LIMITED | Chief Operating Officer | 21/08/2023 |
Former positions of Bradley Glover
| Companies | Position | End |
|---|---|---|
| CELULARITY INC. | Chief Operating Officer | 31/05/2023 |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Chief Tech/Sci/R&D Officer | - |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Training of Bradley Glover
| University of California San Diego | Undergraduate Degree |
| The University of Colorado | Doctorate Degree |
| Rady School of Management at UC San Diego | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IMUGENE LIMITED | Health Technology |
| CELULARITY INC. | Commercial Services |
| Private companies | 2 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Celularity, Inc. (United States)
Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Commercial Services |
- Stock Market
- Insiders
- Bradley Glover
